Tucatinib + Abemaciclib + Herceptin for HER2+ MBC
Clinical trial NCT03846583 · WITHDRAWN
Trial details
- NCT number
- NCT03846583
- Sponsor
- Dana-Farber Cancer Institute
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-28
- Primary completion
- 2020-09-22
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.